Intelliport System Cleared to Improve IV Bolus Management BD announced that the Food and Drug Administration (FDA) has cleared the BD Intelliport Medication Management System, a management system for ...
A phase I/IIa clinical trial of CLAOP21 and CLAOP14 in patients with high-grade non-Hodgkin's lymphoma and cardiac risk factors No significant financial relationships to disclose. This is an ASCO ...
A real-world study conducted across 9 European countries found that bolus injection frequency and engagement with a smart pen to administer insulin were associated with improved glycemic control among ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results